약제 스크리닝 시장 : 제품 유형별, 검체 유형별, 기술별, 최종사용자별, 용도별 - 세계 예측(-2036년)

Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036

According to the research report titled, 'Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036,' the global drug screening market is expected to reach approximately USD 25.3 billion by 2036 from USD 8.29 billion in 2026, at a CAGR of 11.8% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global drug screening market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the drug screening market include escalating global concern over workplace safety, rapid expansion of comprehensive substance abuse prevention programs, and increasing need for high-reliability detection in transportation and healthcare complexes. Additionally, proliferation of oral fluid testing, innovation in rapid testing systems, and regulatory compliance infrastructure development are expected to create significant growth opportunities for players operating in the drug screening market.

Market Segmentation

The drug screening market is segmented by product (analyzers, rapid testing devices, consumables, services), sample type (urine, oral fluid, breath, hair), technology (immunoassay, chromatography, breath analyzers), end user (workplace, drug testing laboratories, hospitals, criminal justice, drug treatment centers), application (drug of abuse testing, alcohol testing), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, the services segment holds the largest market share in 2026, particularly in supporting large-scale laboratory testing operations, comprehensive workplace programs, and superior analytical accuracy in forensic applications. Analyzers represent a significant segment for confirmatory testing and high-volume screening. Rapid testing devices are growing rapidly for point-of-care applications and on-site screening. Consumables represent a steady segment supporting ongoing testing operations.

Based on Sample Type

By sample type, the urine sample segment holds the largest market share in 2026, due to the widespread adoption of standardized testing protocols and established detection windows for diverse substance categories. Oral fluid represents a rapidly growing segment offering improved sample integrity and non-invasive collection. Breath and hair samples represent specialized segments for specific applications and extended detection windows.

Based on Technology

By technology, immunoassay dominates the market for rapid screening applications, offering cost-effectiveness and high-throughput capabilities. Chromatography represents a significant segment for confirmatory testing and complex substance detection. Breath analyzers represent a specialized segment for alcohol testing and impairment assessment. Advanced analytical technologies continue to evolve for improved detection accuracy and expanded substance coverage.

Based on End User

By end user, the workplace segment holds the largest share of the overall market in 2026, driven by stringent regulatory requirements and comprehensive occupational health protocols. Drug testing laboratories represent a significant segment for confirmatory testing and forensic applications. Hospitals, criminal justice systems, and drug treatment centers represent growing segments with specialized testing requirements and regulatory compliance needs.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America dominates the global drug screening market with the largest market share in 2026, driven by stringent workplace regulations and the presence of comprehensive federal testing programs in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing awareness of substance abuse prevention and expanding workplace safety protocols in China, India, and Japan.

Key Players

The key players operating in the global drug screening market are Quest Diagnostics, LabCorp, Abbott Diagnostics, Thermo Fisher Scientific, Alere Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, Bio-Rad Laboratories, Immunalysis Corporation, and Psychemedics Corporation, among others.

Key Questions Answered in the Report

• How big is the global drug screening market?
• What is the growth rate of the global drug screening market?
• Which product segment will dominate and grow the fastest?
• How are oral fluid testing and synthetic substance detection transforming the drug screening landscape?
• Which region leads the global drug screening market?
• Who are the major players in the global drug screening market?
• What are the key trends shaping the drug screening market?
• What are the major opportunities and challenges in the drug screening market?

Scope of the Report:

Drug Screening Market Assessment -- by Product

• Analyzers
• Rapid Testing Devices
• Consumables
• Services

Drug Screening Market Assessment -- by Sample Type

• Urine
• Oral Fluid
• Breath
• Hair

Drug Screening Market Assessment -- by Technology

• Immunoassay
• Chromatography
• Breath Analyzers
• Others

Drug Screening Market Assessment -- by End User

• Workplace
• Drug Testing Laboratories
• Hospitals
• Criminal Justice
• Drug Treatment Centers

Drug Screening Market Assessment -- by Application

• Drug of Abuse Testing
• Alcohol Testing

Drug Screening Market Assessment -- by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Southeast Asia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition
• 1.2. Market Scope
• 1.3. Research Methodology
• 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

• 3.1. Introduction
• 3.2. Market Dynamics
  • 3.2.1. Drivers
  • 3.2.2. Restraints
  • 3.2.3. Opportunities
  • 3.2.4. Challenges
• 3.3. Impact of Regulatory Changes and Synthetic Substances on Drug Screening
• 3.4. Regulatory Landscape & Federal Testing Standards
• 3.5. Porter's Five Forces Analysis

4. Global Drug Screening Market, by Product

• 4.1. Introduction
• 4.2. Analyzers
  • 4.2.1. Immunoassay Analyzers
  • 4.2.2. Chromatography Instruments
  • 4.2.3. Mass Spectrometry Systems
• 4.3. Rapid Testing Devices
  • 4.3.1. Urine Test Kits
  • 4.3.2. Oral Fluid Test Devices
  • 4.3.3. Test Cups & Dip Cards
• 4.4. Consumables
  • 4.4.1. Assay Kits & Reagents
  • 4.4.2. Sample Collection Devices
  • 4.4.3. Calibrators & Controls
• 4.5. Services
  • 4.5.1. Laboratory Testing Services
  • 4.5.2. Workplace Testing Programs
  • 4.5.3. Confirmatory Analysis Services

5. Global Drug Screening Market, by Sample Type

• 5.1. Introduction
• 5.2. Urine Sample
• 5.3. Oral Fluid Sample
• 5.4. Breath Sample
• 5.5. Hair Sample
• 5.6. Others (Blood, Sweat)

6. Global Drug Screening Market, by Technology

• 6.1. Introduction
• 6.2. Immunoassay
  • 6.2.1. Enzyme Immunoassay
  • 6.2.2. Radioimmunoassay
  • 6.2.3. Fluorescence Immunoassay
• 6.3. Chromatography
  • 6.3.1. Gas Chromatography-Mass Spectrometry
  • 6.3.2. Liquid Chromatography-Mass Spectrometry
  • 6.3.3. High-Performance Liquid Chromatography
• 6.4. Breath Analyzers
  • 6.4.1. Fuel Cell Technology
  • 6.4.2. Semiconductor Technology
• 6.5. Others (Spectroscopy, Lab-on-a-Chip)

7. Global Drug Screening Market, by End User

• 7.1. Introduction
• 7.2. Workplace
  • 7.2.1. Pre-employment Screening
  • 7.2.2. Random Testing Programs
  • 7.2.3. Post-accident Testing
• 7.3. Drug Testing Laboratories
• 7.4. Hospitals & Clinics
• 7.5. Criminal Justice & Law Enforcement Agencies
• 7.6. Drug Treatment Centers
• 7.7. Pain Management Centers
• 7.8. Schools & Educational Institutions
• 7.9. Others (Sports Organizations, Personal Users)

8. Global Drug Screening Market, by Application

• 8.1. Introduction
• 8.2. Drug of Abuse Testing
  • 8.2.1. Cannabis/Marijuana Testing
  • 8.2.2. Opioid Testing
  • 8.2.3. Cocaine Testing
  • 8.2.4. Amphetamine Testing
  • 8.2.5. Synthetic Drug Testing
• 8.3. Alcohol Testing
• 8.4. Others (Prescription Drug Monitoring, Sports Doping)

9. Global Drug Screening Market, by Region

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Netherlands
  • 9.3.7. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. China
  • 9.4.2. India
  • 9.4.3. Japan
  • 9.4.4. South Korea
  • 9.4.5. Australia
  • 9.4.6. Southeast Asia
  • 9.4.7. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Middle East & Africa
  • 9.6.1. Saudi Arabia
  • 9.6.2. UAE
  • 9.6.3. South Africa
  • 9.6.4. Rest of Middle East & Africa

10. Competitive Landscape

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
  • 10.4.4. Emerging Companies
• 10.5. Market Ranking / Positioning Analysis of Key Players, 2025

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

• 11.1. Quest Diagnostics Incorporated
• 11.2. Laboratory Corporation of America Holdings (LabCorp)
• 11.3. Abbott Laboratories
• 11.4. Thermo Fisher Scientific Inc.
• 11.5. F. Hoffmann-La Roche Ltd.
• 11.6. Siemens Healthineers AG
• 11.7. Dragerwerk AG & Co. KGaA
• 11.8. OraSure Technologies Inc.
• 11.9. Bio-Rad Laboratories, Inc.
• 11.10. Lifeloc Technologies, Inc.
• 11.11. Premier Biotech, Inc.
• 11.12. Omega Laboratories, Inc.
• 11.13. Psychemedics Corporation
• 11.14. Alfa Scientific Designs, Inc.
• 11.15. MPD Inc.

12. Appendix

• 12.1. Questionnaire
• 12.2. Related Reports